Research
Simple Lab Test May Predict Recurrence Risk in Most Common Type of Breast Cancer
The Brief
- A large retrospective study found that higher circulating eosinophil levels were significantly associated with improved recurrence-free survival (RFS) in hormone receptor (HR)-positive breast cancer.
- The same study found a significant association between higher eosinophil levels and improved distant metastasis-free survival (DMFS).
- The finding comes from a simple blood-based lab measure, reported by MedPage Today.
Why it matters
If confirmed, a routine blood test for eosinophils could help estimate recurrence and metastasis risk in HR-positive breast cancer, the most common type. The study is retrospective, so it shows an association rather than proof of predictive value.
Who’s affected
- oncologists and clinicians treating HR-positive breast cancer
- researchers studying blood-based biomarkers for cancer prognosis
- #breast cancer
- #eosinophils
- #biomarkers
- #recurrence
- #oncology
(MedPage Today) -- Higher levels of circulating eosinophils had a significant association with improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) in hormone receptor (HR)-positive breast cancer, a large retrospective...